Invech Holdings enters finder agreement with Craft Capital; amends Series A Preferred

This filing

On March 30, 2026, the Board of Directors and the sole shareholder of the Series A Preferred Stock of the Company (the “Series A Preferred”) authorized and approved an amended and restated Certificate of Designation of the Series A Preferred Stock of the Company

Comparable filing

the Board of Directors of the Company amended Section 3.3 of Article III of the Company’s Amended and Restated By-Laws (the “ By-Laws Amendment ”) to permit the removal of a director with or without cause by the affirmative vote of two-thirds of the outstanding shares of capital stock of the Company entitled to vote at a meeting of shareholders duly called for such purpose. The effective date of the By-Laws Amendment is May 8, 2026.

This filing

On March 30, 2026, the Board of Directors and the sole shareholder of the Series A Preferred Stock of the Company (the “Series A Preferred”) authorized and approved an amended and restated Certificate of Designation of the Series A Preferred Stock of the Company

Comparable filing

On May 6, 2026, the Company filed a Certificate of Designations, Powers, Preferences and Rights with the Secretary of State of the State of Delaware, establishing the rights, preferences, privileges, qualifications, restrictions and limitations relating to the Series PP Preferred Stock

This filing

On March 30, 2026, the Board of Directors and the sole shareholder of the Series A Preferred Stock of the Company (the “Series A Preferred”) authorized and approved an amended and restated Certificate of Designation of the Series A Preferred Stock of the Company

Comparable filing

On May 7, 2026, KALA BIO, Inc. (the “ Company ”) filed a Certificate of Amendment (the “ Certificate of Amendment ”) to the Company’s Restated Certificate of Incorporation (as amended, the “ Certificate of Incorporation ”) with the Secretary of State of Delaware to effect a 1-for-50 reverse stock split of the shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), either issued and outstanding or held by the Company as treasury stock, effective as of 4:05 p.m. (Delaware time) on May 8, 2026 (the “ Reverse Stock Split ”).

This filing

On March 30, 2026, the Board of Directors and the sole shareholder of the Series A Preferred Stock of the Company (the “Series A Preferred”) authorized and approved an amended and restated Certificate of Designation of the Series A Preferred Stock of the Company

Comparable filing

On May 4, 2026, Stonepeak-Plus Infrastructure Fund Associates LP, the general partner of the Fund (the “General Partner”), entered into the Third Amended and Restated Limited Partnership Agreement of the Fund (the “Amended Partnership Agreement”), to (i) authorize the General Partner to cause the Fund to issue Units designated as Class Z - Series D-2 Units, Class Z - Series I-2 Units and Class Z - Series S-2 Units, and cancel Class D-2 Units, Class I-2 Units and Class S-2 Units, each of which have not been issued, and (ii) make certain related changes and incorporate other administrative updates.

This filing

On March 30, 2026, the Board of Directors and the sole shareholder of the Series A Preferred Stock of the Company (the “Series A Preferred”) authorized and approved an amended and restated Certificate of Designation of the Series A Preferred Stock of the Company

Comparable filing

At the 2026 Annual Meeting of Shareholders, held on April 28, 2026, BancPlus Corporation (the “Company”) approved an amendment to its Articles of Incorporation to phase out the classified structure of its Board of Directors (the “Board”) over a three‐year period, beginning with the 2026 Annual Meeting of Shareholders and concluding at the 2028 Annual Meeting of Shareholders, at which time all directors will be elected annually (the “Declassification Amendment”).

This filing

On March 30, 2026, the Board of Directors and the sole shareholder of the Series A Preferred Stock of the Company (the “Series A Preferred”) authorized and approved an amended and restated Certificate of Designation of the Series A Preferred Stock of the Company

Comparable filing

On April 30, 2026, the Company executed its Second Amended and Restated Limited Liability Company Agreement (the "Second A&R LLCA"), which amended and restated the Company’s Amended and Restated Limited Liability Company Agreement, dated as of January 30, 2026.

This filing

On March 30, 2026, the Board of Directors and the sole shareholder of the Series A Preferred Stock of the Company (the “Series A Preferred”) authorized and approved an amended and restated Certificate of Designation of the Series A Preferred Stock of the Company

Comparable filing

On April 27, 2026, in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association (the “Amended Charter”), effective the same day.

This filing

On March 30, 2026, the Board of Directors and the sole shareholder of the Series A Preferred Stock of the Company (the “Series A Preferred”) authorized and approved an amended and restated Certificate of Designation of the Series A Preferred Stock of the Company

Comparable filing

On April 27, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on April 27, 2026.